BNP Paribas Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-107,808
| Closed | -$18.6M | – | 960 |
|
|
2021
Q3 | $18.6M | Sell |
107,808
-75,566
| -41% | -$13M | 0.07% | 310 |
|
|
2021
Q2 | $23M | Buy |
183,374
+33,634
| +22% | +$4.22M | 0.08% | 282 |
|
|
2021
Q1 | $20.3M | Sell |
149,740
-45,157
| -23% | -$6.12M | 0.08% | 281 |
|
|
2020
Q4 | $24.9M | Buy |
194,897
+81,205
| +71% | +$10.4M | 0.12% | 214 |
|
|
2020
Q3 | $12.8M | Buy |
113,692
+34,936
| +44% | +$3.93M | 0.07% | 285 |
|
|
2020
Q2 | $7.5M | Buy |
78,756
+60,352
| +328% | +$5.75M | 0.05% | 354 |
|
|
2020
Q1 | $1.65M | Sell |
18,404
-2,654
| -13% | -$239K | 0.01% | 558 |
|
|
2019
Q4 | $1.12M | Buy |
+21,058
| New | +$1.12M | 0.01% | 646 |
|